Bivalent COVID-19 vaccines show higher effectiveness against thromboembolic events

Study finds bivalent mRNA COVID-19 vaccines are more effective than monovalent vaccines in preventing thromboembolic events in older adults and those with end-stage renal disease.

Regeneron expands CRISPR deal with Intellia; Capsida, Kate’s gene therapy manufacturing deal; Biohaven’s $225M offering

Plus, Codagenix to advance Covid-19 nasal vaccine with BARDA support. Regeneron, Intellia extend CRISPR deal: Regeneron Pharmaceuticals and Intellia Therapeutics are expanding their pact to

October 4, 2023

Adding Tirzepatide to Basal Insulin Cuts HbA1c in Poorly Controlled T2D

HAMBURG, Germany — Adding weekly tirzepatide (Mounjaro) to basal insulin reduced HbA1c in patients with poorly controlled type 2 diabetes compared with adding three-times-daily insulin

October 4, 2023

Nearly one-third of Americans exposed to unregulated contaminants in drinking water

Researchers assess socioeconomic disparities in exposure to unregulated contaminants present in public water systems throughout the United States.

January 22, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.